Clinical Trials
2 trialsNCT00900757 2019-08-28
Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
Duke University
Phase 2 Completed
NCT00636805 2014-04-01
Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab
Duke University
Phase 2 Terminated